Eris Lifesciences announced that its board has sanctioned the purchase of the remaining 30 percent share in its subsidiary Swiss Parenterals
Saviynt, the worldwide leader in AI-driven identity security and governance solutions, revealed that Narayana Health, one of India’s largest and most trusted healthcare networks, has implemented the Saviynt Identity Cloud to upgrade identity
Apollo Hospitals opened its latest healthcare facility in Swargate, Pune, on Monday, marking its third hospital in Maharashtra and further expanding its presence in western India
.png "Lilly Unveils New Breakthrough Data in HR+ Breast Cancer at SABCS")
Eli Lilly and Company is preparing to unveil a slate of new findings at the San Antonio Breast Cancer Symposium (SABCS), running December 9–12. The update shines a spotlight on fresh progress in HR+ breast cancer, the most common form of the...
Bayer reported a major step forward today as its experimental drug asundexian reduced the risk of recurrent ischemic stroke without increasing bleeding risk in a global phase III study. The OCEANIC-STROKE trial hit both its primary efficacy and...
The European Commission has approved the denosumab biosimilar AVT03 marketing. This license allows the Dr.?Reddy’s Laboratories to provide new options of treatment all over the EU and the European Economic Area...
Alkem Laboratories Ltd has introduced DSS, the original De Simone formulation probiotic mixture in India, aimed at restoring gut microbiota equilibrium and addressing several gut-related health issues.
Shilpa Medicare, Eight Observations, Unit IV, Jadcherla Telangana, Ten-Day Inspection, Sterile Injectables, Oral Tablets, Capsule Production, Regulatory Approvals, US Sales, Key Agencies, Consolidated Profit
The Central Drugs Standard Control Organisation (CDSCO) has informed procurement agencies, including hospitals, that a license from Indian licensing authorities must be obligatory for acquiring devices, with additional certifications required beyond
Roche has received conditional marketing approval in Europe for Lunsumio, a new subcutaneous form of its bispecific antibody that can be administered in a quick, one?minute injection. This approval marks one of the significant changes in the...
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")